BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29566279)

  • 1. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
    Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
    Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
    Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
    Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
    Giefing M; Zemke N; Brauze D; Kostrzewska-Poczekaj M; Luczak M; Szaumkessel M; Pelinska K; Kiwerska K; Tönnies H; Grenman R; Figlerowicz M; Siebert R; Szyfter K; Jarmuz M
    Genes Chromosomes Cancer; 2011 Mar; 50(3):154-66. PubMed ID: 21213369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
    Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
    Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
    Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
    Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
    Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
    J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
    Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
    Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation reduced the expression of protocadherin 17 in nasopharyngeal cancer.
    Yang S; Dai Z; Li W; Wang R; Huang D
    Biochem Cell Biol; 2019 Aug; 97(4):364-368. PubMed ID: 30165032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma.
    Ren G; Zhao DA; Xu J; Li BA
    Tumori; 2015; 101(2):215-22. PubMed ID: 25838250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
    Lin YL; Wang YP; Li HZ; Zhang X
    Med Sci Monit; 2017 Jul; 23():3318-3323. PubMed ID: 28688232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
    López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
    Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer.
    Yang Y; Liu J; Li X; Li JC
    Histol Histopathol; 2012 Feb; 27(2):217-24. PubMed ID: 22207556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
    Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
    Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.